HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex.

Abstract
Retinoic acid receptor alpha 1 (RAR alpha 1) gene expression is induced by 17 beta-estradiol (E2) in estrogen receptor (ER)-positive breast cancer cells, and the -100 to -49 region of the RAR alpha 1 gene promoter was previously shown to be required for E2-responsiveness. This region of the RAR alpha 1 promoter was further analyzed using the following oligonucleotides: -100 to -49 (RAR4); -79 to -56 (RAR3); -79 to -49 (RAR2); -100 to -58 (RAR1); and their derived promoter reporter constructs (pRAR4, pRAR3, pRAR2, and pRAR1). In transient transfection studies in MCF-7 human breast cancer cells, pRAR2 and pRAR1 were E2-responsive; both of the RAR alpha 1 gene promoter inserts contained two GC-rich sites and bound Sp1 protein in gel mobility shift assays. Using wild-type [32P]RAR2 and oligonucleotides mutated in one or both GC-rich sites, it was shown that ER enhanced Sp1 binding to both sites, but a ternary ER-Sp1-DNA complex was not observed in gel mobility shift assays. In transient transfection assays, each of the GC-rich motifs were sufficient for E2-induced transactivation. In ER-negative MDA-MB-231 cells transiently transfected with pRAR2, E2 responsiveness was observed only in cells cotransfected with wild-type ER or 11C-ER containing a deletion of the DNA-binding domain but not with ER variants that express activation function-1 (AF-1) or AF-2. Using a similar approach, it was shown that the GC-rich sites in RAR1 were also sufficient for ER activation. These results demonstrate that interaction of a transcriptionally active ER/Sp1 complex with GC-rich motifs is required for hormone inducibility of the downstream region of the RAR alpha 1 gene promoter.
AuthorsG Sun, W Porter, S Safe
JournalMolecular endocrinology (Baltimore, Md.) (Mol Endocrinol) Vol. 12 Issue 6 Pg. 882-90 (Jun 1998) ISSN: 0888-8809 [Print] United States
PMID9626663 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Estrogens
  • Macromolecular Substances
  • Neoplasm Proteins
  • RARA protein, human
  • Receptors, Estrogen
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Sp1 Transcription Factor
  • Estradiol
Topics
  • Adenocarcinoma (pathology)
  • Breast Neoplasms (pathology)
  • Estradiol (pharmacology)
  • Estrogens
  • Female
  • Gene Expression Regulation (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Macromolecular Substances
  • Neoplasm Proteins (biosynthesis, genetics)
  • Neoplasms, Hormone-Dependent (pathology)
  • Promoter Regions, Genetic
  • Receptors, Estrogen (physiology)
  • Receptors, Retinoic Acid (biosynthesis, genetics)
  • Retinoic Acid Receptor alpha
  • Sequence Deletion
  • Sp1 Transcription Factor (physiology)
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: